Procaps Group S.A.

NASDAQ:PROC

2.35 (USD) • At close December 27, 2024
Bedrijfsnaam Procaps Group S.A.
Symbool PROC
Munteenheid USD
Prijs 2.35
Beurswaarde 265,136,400
Dividendpercentage 0%
52-weken bereik 0.5 - 4.95
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Ruben Minski
Website https://www.procapsgroup.com

An error occurred while fetching data.

Over Procaps Group S.A.

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital

Vergelijkbare Aandelen

OrthoPediatrics Corp. logo

OrthoPediatrics Corp.

KIDS

22.89 USD

Cerus Corporation logo

Cerus Corporation

CERS

1.56 USD

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI

6.98 USD

Sharecare, Inc. logo

Sharecare, Inc.

SHCR

1.43 USD

Morphic Holding, Inc. logo

Morphic Holding, Inc.

MORF

56.99 USD

Revance Therapeutics, Inc. logo

Revance Therapeutics, Inc.

RVNC

3.06 USD

National Research Corporation logo

National Research Corporation

NRC

17.43 USD

Varex Imaging Corporation logo

Varex Imaging Corporation

VREX

14.82 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

7.41 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)